Literature DB >> 26192143

Severe Cholestatic Hepatitis C in Transplant Recipients: No Longer a Threat to Graft Survival.

Jeanne-Marie Giard1, Norah A Terrault1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26192143      PMCID： PMC4615527          DOI： 10.1016/j.cgh.2015.07.018

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  27 in total

Review 1.  Post-liver transplant cholestatic hepatitis C: a systematic review of clinical and pathological findings and application of consensus criteria.

Authors:  Tarun K Narang; Will Ahrens; Mark W Russo
Journal:  Liver Transpl       Date:  2010-11       Impact factor: 5.799

2.  Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.

Authors:  B Cimsit; D Assis; C Caldwell; A Arvelakis; T Taddei; S Kulkarni; M Schilsky; S Emre
Journal:  Transplant Proc       Date:  2011-04       Impact factor: 1.066

3.  Liver transplantation in adults coinfected with HIV.

Authors:  A A Prachalias; A Pozniak; C Taylor; P Srinivasan; P Muiesan; J Wendon; M Cramp; R Williams; J O'Grady; M Rela; N D Heaton
Journal:  Transplantation       Date:  2001-11-27       Impact factor: 4.939

4.  Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation.

Authors:  Xavier Forns; Michael Charlton; Jill Denning; John G McHutchison; William T Symonds; Diana Brainard; Theo Brandt-Sarif; Paul Chang; Valerie Kivett; Lluís Castells; Martín Prieto; Robert J Fontana; Thomas F Baumert; Audrey Coilly; Maria Carlota Londoño; François Habersetzer
Journal:  Hepatology       Date:  2015-03-20       Impact factor: 17.425

5.  Safe and effective treatment with daclatasvir and asunaprevir in a liver transplant recipient with severe cholestatic hepatitis C.

Authors:  Yoshihide Ueda; Toshimi Kaido; Etsuro Hatano; Shigeru Ohtsuru; Shinji Uemoto
Journal:  Hepatol Res       Date:  2015-04-27       Impact factor: 4.288

6.  Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study.

Authors:  Elizabeth C Verna; Varun Saxena; James R Burton; Jacqueline G O'Leary; Jennifer L Dodge; Richard T Stravitz; Josh Levitsky; James F Trotter; Gregory T Everson; Robert S Brown; Norah A Terrault
Journal:  Transplantation       Date:  2015-08       Impact factor: 4.939

7.  Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis.

Authors:  Klaus Radecke; Nils R Frühauf; Michael Miller; Birgit Ross; Roland Köditz; Massimo Malagó; Christoph E Broelsch; Guido Gerken; Ulrich Treichel
Journal:  Liver Int       Date:  2005-02       Impact factor: 5.828

8.  Evolution of hepatitis C virus in liver allografts.

Authors:  Anthony J Demetris
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

9.  Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis.

Authors:  S E Davies; B C Portmann; J G O'Grady; P M Aldis; K Chaggar; G J Alexander; R Williams
Journal:  Hepatology       Date:  1991-01       Impact factor: 17.425

Review 10.  Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review.

Authors:  Andres Duarte-Rojo; Vikram Budhraja; Bart J Veldt; David D Goldstein; Kymberly D Watt; Julie K Heimbach; John G McHutchison; Hans L Tillman; John J Poterucha; Michael R Charlton
Journal:  Liver Transpl       Date:  2013-12       Impact factor: 5.799
View more
  2 in total

1.  How I treat hepatitis C virus infection in patients with hematologic malignancies.

Authors:  Harrys A Torres; George B McDonald
Journal:  Blood       Date:  2016-07-21       Impact factor: 22.113

Review 2.  Mechanisms of liver disease in patients infected with HIV.

Authors:  Matthew B Kaspar; Richard K Sterling
Journal:  BMJ Open Gastroenterol       Date:  2017-10-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.